Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study.
Fahim EbrahimiTracey G SimonHannes HagströmJiangwei SunDavid BergmanAnders ForssBjorn RoelstraeteLars EngstrandJonas F LudvigssonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
Antibiotic use may be a risk factor for incident NAFLD, especially in individuals without the metabolic syndrome. The risk was highest for fluoroquinolones and remained robust in sibling comparisons with whom individuals share genetic and early environmental susceptibilities.